Occipital Nerve Stimulation for Chronic Migraine
- 398 Downloads
Occipital nerve stimulation may be effective in treating chronic migraine. Six studies, including three double-blind studies, were performed, with five showing evidence of benefit. However, of the three randomized, controlled trials, none has met a primary endpoint successfully. A separate study suggested a benefit for combined supraorbital and greater occipital nerve stimulation.
KeywordsChronic migraine Migraine Occipital nerve Occipital nerve stimulation
Compliance with Ethics Guidelines
Conflict of Interest
Dr. William B. Young declares no potential conflicts of interest relevant to this article.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 3.Headache Classification Committee. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia. 2004;24:1–160.Google Scholar
- 11.••Reed KL, Black SB, Banta CJ, et al. Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experience. Cephalalgia. 2010;30:260–71. Study examines combined occipital and supraorbital nerve stimulation. Combined stimulation was substantially more effective than previous reports for ONS alone.PubMedGoogle Scholar
- 12.•Lipton RB, Goadsby PJ, Cady RK, et al. PRISM study: occipital nerve stimulation for treatment-refractory migraine. Cephalalgia. 2009;29:30-Abstract PO47. The third sham-controlled trial. Results were negative and only the abstract was reported Google Scholar
- 13.••Saper JR, Dodick DW, Silberstein SD, et al. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011;31:271–85. Double-blind, sham-controlled trial to explore various endpoints. Occipital nerve block responders were excluded, but implanted.PubMedCentralPubMedCrossRefGoogle Scholar
- 14.••Silberstein SD, Dodick D, Saper J, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blind, controlled study. Cephalalgia. 2012;32:1165–79. Large, double-blind, controlled study. The primary endpoint of 50 % improvement in average VAS score proved negative. A 30 % improvement would have proved positive.PubMedCrossRefGoogle Scholar
- 24.Oshinsky ML, Hirata H, Poletto C, et al. Dural sensitization is suppressed by occipital nerve stimulation. 701.07/RR2. Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience; 2011.Google Scholar
- 26.•Lambru G, Matharu MS. Occipital nerve stimulation in primary headache syndromes. Ther Adv Neurol Disord. 2012;5:57–67. A well-written review of ONS in not just CM, but cluster headache, hemicrania continua, and Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) and Short-lasting Unilateral Neuralgiform headache Attacks with cranial autonomic features (SUNA).Google Scholar